The CML Content Hub Channel
Case Studies | Acute & Chronic Myeloid Leukemia | Redcliffe Labs
CML Content Hub
Yogitha Namasani, MD discusses two recent leukemia cases. The first involved a patient with acute leukemia diagnosed through peripheral smear, flow cytometry, and bone marrow studies, which confirmed…
Chronic Myelogenous Leukemia (CML) | Pathology of CML | Diagnosis and treatment of CML | USMLE
CML Content Hub
This is a comprehensive overview of Chronic Myelogenous Leukemia (CML), a rare type of cancer affecting bone marrow and blood cell development. Arpan Parichha, MD discusses the disease’s…
Recent Videos in CML Content Hub Page 3
Prior Bariatric Surgery: Suggestive of Worse Outcomes in CML Patients
CML Content Hub
@FadiHaddad_MD of @MDAndersonNews, discusses #bariatric surgery in #CML.
Promising Two-Year Trial Data on Asciminib vs Bosutinib
CML Content Hub
Timothy Hughes, MD, of @sahmriAU, discusses improved #outcomes with #asciminib.
Progress Toward Treatment Discontinuation in CML
CML Content Hub
@GCC_Cortes of @GACancerCenter discusses treatment #discontinuation among patients with #CML.
Multidisciplinary Management of Chronic Myeloid Leukemia in the Later-Line Setting
CML Content Hub
Experts discuss the importance of a #multidisciplinary #team in the #management of #CML.
Chronic Phase CML Treatment: A New Drug Option and Discontinuation of TKI Therapy
CML Content Hub
@GabyHobbs, of @MGHCancerCenter, discusses #asciminib for #CML.
Balancing Toxicity and Response in Ph+ CML Treatment
CML Content Hub
B Douglas Smith, MD, of @JohnsHopkins, discusses #balance between #toxicity and #response in #CML.
Safety and Efficacy of Asciminib in Third-Line Treatment for CML
CML Content Hub
@mjmauroMD, of @MSKCancerCenter, discusses #third-line treatment for #CML.
Well Tolerated in Preliminary Study: Pembrolizumab + TKIs in CML Patients With Persistent Detectible MRD
CML Content Hub
@Dr_AmerZeidan, of @Yale, discusses #safety of #pembrolizumab plus #TKIs in #CML.
Restoring Sensitivity to TKIs in CML With BCR-ABL1 Mutation
CML Content Hub
Michael Deininger, MD, PhD, of @MedicalCollege, discusses restoring #sensitivity in #TKI-resistant #CML.
CML Recurrence Mechanism Poorly Understood
CML Content Hub
Francois-Xavier Mahon, MD, PhD, of @univbordeaux_EN, discusses #recurrence in #CML.